Nearly 113,000 Bottles of Generic Acetaminophen Sold on Amazon Recalled Over Discolored Tablets
Nearly 113,000 bottles of generic acetaminophen sold on Amazon are being recalled over reports of discolored tablets. Check affected lot numbers, UPCs, expiration dates, and FDA guidance.
What Consumers Need to Know About the 2026 Acetaminophen Recall
Nearly 113,000 bottles of generic acetaminophen sold through Amazon are being recalled following consumer complaints about discolored tablets, according to notices published in the U.S. Food and Drug Administration (FDA) recall database.
The recall affects 112,932 bottles of 500-milligram acetaminophen caplets distributed by Amazon.com Services LLC and manufactured by Aurobindo Pharma USA Inc. The affected products were packaged in bottles containing 200, 500, or 1,000 caplets.
The manufacturer initiated the recall on September 18, 2026. However, the FDA's public database added the notices during the week before the report's October 5 publication.
Consumers who purchased generic acetaminophen through Amazon should check their bottles carefully to determine whether their products match the recalled lot numbers and identification codes.
Importantly, Tylenol-branded products are not included in this recall, according to the published report.
Why Is the Acetaminophen Being Recalled?
The stated reason for the recall is tablet discoloration following complaints from consumers.
According to the FDA notices, the reason was listed as "discoloration: consumer complaints received for discolored tablets." The agency did not provide further details about the appearance of the affected tablets or explain what caused the discoloration.
Discoloration can be a visible sign that a medicine may not meet expected quality standards. However, the available notices do not establish the precise cause of the reported changes or confirm whether the affected tablets pose a specific health risk.
At the time of the reported announcement, the FDA had not assigned a recall classification to the three newly posted actions. The notices also did not provide specific instructions regarding returning, disposing of, or continuing to use the affected products.
Consumers should therefore avoid making assumptions about the safety of a bottle based solely on its appearance or the absence of visible changes.
Which Acetaminophen Bottles Are Included?
The recall covers three packaging sizes of 500-milligram generic acetaminophen caplets. Consumers should compare the information printed on their packaging with the details below.
1. Bottles Containing 500 Caplets
This is the largest group affected by the recall, accounting for 90,456 bottles.
- National Drug Code (NDC): 72288-692-50
- UPC: 1 95515 04890 3
- Affected lot numbers: ACD124036A, ACD124030A, ACD124042A, ACD124048B, and ACD125010A
- Expiration dates: September 30, 2027; October 31, 2027; November 30, 2027; and February 29, 2028, depending on the lot
Check the specific lot number and expiration date on your bottle rather than relying on the packaging size alone.
2. Bottles Containing 200 Caplets
A total of 14,640 bottles in the 200-count packaging size are included.
- NDC: 72288-692-20
- UPC: 1 95515 04887 3
- Affected lot number: ACD125040A
- Expiration date: September 30, 2027
Consumers who purchased this package size should verify all identifying details before determining whether their product is affected.
3. Bottles Containing 1,000 Caplets
The recall also covers 7,836 bottles containing 1,000 caplets.
- NDC: 72288-692-01
- UPC: 1 95515 04888 0
- Affected lot number: ACD124048A
- Expiration date: November 30, 2027
These identifiers can help consumers distinguish affected bottles from products that are not listed in the current recall notices.
What Should Consumers Do if They Have the Recalled Medicine?
If you purchased generic acetaminophen on Amazon, take a few minutes to inspect the packaging.
First, check the product strength and packaging size. The current recall covers 500-milligram caplets sold in 200-count, 500-count, and 1,000-count bottles.
Second, locate the lot number and expiration date. Compare these details with the affected lots listed above. The NDC and UPC can provide additional confirmation.
Third, consult the official FDA recall database. Review the notices for the latest information and any updated instructions. The FDA had not provided specific consumer directions in the notices described in the October 5 report.
If your bottle matches an affected lot, contact the manufacturer, Amazon customer service, or a pharmacist for guidance on what to do next. Do not assume that a product is safe simply because its tablets appear normal.
If you have already taken the medicine and are concerned about a possible reaction, seek advice from a healthcare professional. For severe or urgent symptoms, obtain emergency medical assistance.
Consumers should also avoid taking additional doses from a potentially affected bottle until they have received appropriate guidance.
Previous Acetaminophen Recall Raises Additional Questions
This is not the first time Aurobindo has recalled acetaminophen sold through Amazon because of tablet discoloration.
In the previous year, the company recalled 4,608 bottles of 325-milligram acetaminophen after receiving confirmed consumer complaints involving tablets with brown surfaces.
That earlier recall involved a different dosage strength from the 500-milligram products covered by the latest actions.
The previous recall notice also cited deviations from current good manufacturing practice, commonly abbreviated as cGMP. The FDA classified that action as Class II.
According to the FDA, a Class II recall involves a situation in which exposure to a violative product may cause temporary or medically reversible adverse health consequences, or in which the probability of serious adverse health consequences is remote.
However, consumers should not assume that the current recall carries the same classification. The FDA had not assigned a classification to the newly reported actions at the time of publication.
The report also noted that Aurobindo had received FDA warning letters in 2019 and 2022 following inspections at manufacturing facilities in India. Those letters cited significant deviations from current good manufacturing practice.
These previous regulatory actions provide context, but they do not independently establish the cause or health consequences of the latest tablet discoloration complaints.
Are Tylenol Products Affected by This Recall?
No. According to the published report, Tylenol products are not included in the current recall.
Acetaminophen is the active ingredient in Tylenol and is widely used to relieve pain and reduce fever. Generic versions contain the same active ingredient, although products can differ in manufacturers, packaging, and other inactive ingredients.
The current action specifically identifies certain lots of Aurobindo-manufactured, 500-milligram generic acetaminophen distributed through Amazon.com Services LLC.
Consumers should use the official product identifiers rather than assuming that every acetaminophen product, generic or branded, is affected.
Final Thoughts
The recall of 112,932 bottles of generic acetaminophen highlights the importance of checking medicine packaging and staying informed about official safety announcements.
Although the reported reason is tablet discoloration, the FDA notices described in the report did not establish the precise cause, assign a recall classification, or provide detailed consumer instructions at the time they were published.
Anyone who purchased the affected generic pain reliever should verify the NDC, UPC, lot number, and expiration date against the official recall information and contact a pharmacist, the manufacturer, or Amazon for further guidance.
Checking these details can help consumers identify potentially affected products and make informed decisions about their medicines.
Source
- U.S. Food and Drug Administration (FDA)
Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice. Recall information and regulatory classifications may change as authorities publish updates. Consumers should consult the official FDA notices, a pharmacist, or a qualified healthcare professional for product-specific guidance. Do not rely solely on this article to determine whether a medicine is safe to use.